PILOT STUDY ENROLLMENT Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder (ASD) “Fever Effect” Pilot Study Enrollment Announced SAN DIEGO, CA – June 12, 2018 – AVACEN Medical, Inc. (AVACEN), announced that it will be sponsoring a 12-family blinded, double placebo-controlled pilot study of ASD children ages 6-16 who will be using the AVACEN 100 dry heat therapy, FDA-cleared, medical device which simulates the effect of a…

Read more

Changing Pain Treatment

  Profoundly Changes Pain Treatment Over the last 2 years, AVACEN Medical has been awarded 4 U.S. and 9 International patents for its unique apparatus and methods that support its innovative medical process called The AVACEN Treatment Method (ATM). AVA’S ARE THE KEY With over 3,000 programmed microprocessor instructions, the AVACEN 100 manages the noninvasive and safe continued infusion…

Read more

The Benefits of Micro Circulation

The AVACEN 100, Class-IIa, OTC medical device has been awarded the European Union CE (Conformité Européenne) Mark and is approved by Health Canada for the temporary increase of microcirculation. AVACEN 100 U.S. FDA-Clearance: A heat therapy system indicated for the temporary relief of minor muscle and joint pain and stiffness; the temporary relief of joint pain associated with arthritis;…

Read more